openPR Logo
Press release

Multiplex Biomarker Imaging Market Segments, Opportunity, Growth and Forecast By End-use Industry 2017 – 2027

07-21-2017 01:31 PM CET | Health & Medicine

Press release from: Future Market Insights

Multiplex Biomarker Imaging Market Segments, Opportunity,

Multiplex biomarker imaging is unique technique for imaging the characteristic and analysis of exact disease. Biomarker are the biological markers used for clinical studies to visualize the presence state of the disease. The biomarker have significant use in medical industry, biomarker use alone or as combination to assess to characterized and evaluated as an indicator of normal biological processes. There are various technique for imaging all of them have a specific role for analysis and respecting the data of clinical research related to immune response or cancer. Multiplex biomarker play a crucial role to study the complex biological system by providing the analysis to monitor the expression of multiple biomarkers.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3526

Multiplex Biomarker Imaging Market:Drivers and Restraints

Multiplex biomarker imaging market is expected to be get bigger market over the forecasted years as there is the increase in health related issue (tumor in brain, view RNA detection of miR 133). TMA will be the lead for this industry as it’s cost effective and provide better analysis results for thousands of tissue in a single run, another technique is TIS which is also a potential for the discovery of anticancer drug by identifying proteins that are essential regulation of protein networks other technique are also valuable as this for multiplex biomarker imaging. The restrains are the policy of government and ethical issue and complex process.

Multiplex Biomarker Imaging Market:Segmentation

Multiplex biomarker imaging market is segmented as followed:

Segmentation by imaging techniques:

Immunohistochemistry (IHC) assay

Immunofluorescence (IF) assay

Fluorescent in situ hybridization (FISH) assay

Tissue microarray (TMA) assay

Toponome imaging system (TIS)

Segmentation by application:

Oncology Studies

Drug safety

Genetic characterization studies

Segmentation by end user:

Research Institutes government and private

Pharmaceutical and Biotechnology Company

Clinical Labs

Multiplex Biomarker Imaging Market:Overview

Multiplex biomarker imaging market is highly fragmented as the players in this segment are having a vast range of product like (Vectra 3.0 for 6 to 200 slides from PerkinElmer Inc). Multiplex biomarker imaging provides a successful identification and validation of clinical data related to immune cells, csssancer cells. IHC (immunohistochemistry) is used to identify and co-localize antigens in cell and tissue, but the validation of IHC assay has undertaken by using TMA (Tissue microarray). So as the modern research will be using the TMA as its enables high throughput tissue analysis, up to 1000 minute tissue sample are brought into array format and analysis. TMA is much faster and cost effective as of other techniques.

Multiplex Biomarker Imaging Market:Region-wise Outlook

Geographically, multiplex biomarker imaging market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. Asia pacific will be the growing market as the research is going on for the treatment in chronic disease (cancer, tumor). As per WHO 8.2 million people die in 2015 due to cancer, this motives the industry for more growth in Asia-pacific in terms of research using multiplex biomarker imaging for pre-diagnosis. One of the players like Bio-Rad Laboratories, Inc has a product for multiplex biomarker imaging name as ZOE TM, S3eTM.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3526

Multiplex Biomarker Imaging Market:Key Players

Some players in multiplex biomarker imaging markets are: Thermo Fisher Scientific (Pierce), PerkinElmer Inc (Vectra® 3.0), US Biomax Inc (FDA999b, FDA808c), Bio-Rad Laboratories, Inc (ZOE TM, S3eTM), and Abcam plc.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiplex Biomarker Imaging Market Segments, Opportunity, Growth and Forecast By End-use Industry 2017 – 2027 here

News-ID: 636221 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Multiplex

Preference of Multiplex Assays over Conventional Assays Boosts Global Multiplex …
According to a new market research report launched by Inkwood Research, the Global Multiplex Assay Market is estimated to reach around $7922.13 million by 2028, progressing with a CAGR of 8.74% over the forecasting years. Browse 61 market data Tables and 51 Figures spread over 230 Pages, along with in-depth analysis on Global Multiplex Assay Market by Type, End-User, Product, Technology, Application & by Geography. This insightful market research report by Inkwood
Multiplex Assays Market Future Adoption Overview 2028
Multiplex Assays Market: Snapshot The global multiplex assays market has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about the
Multiplex Assays Market Segmented into types, Applications 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Malleable Strategies in 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Prominent Growth Rate by 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising